NASDAQ:NVIV
InVivo Therapeutics Holdings Corp.
- Stock
Last Close
0.49
12/02 21:00
Market Cap
995.92K
Beta: 0.82
Volume Today
1.61M
Avg: 100.11K
PE Ratio
−0.09
PFCF: −0.08
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||||
average payables | 1.03M - | 734.13K 28.44% | 545K 25.76% | 766K 40.55% | 999.50K 30.48% | 901.50K 9.80% | 878.50K 2.55% | 711.50K 19.01% | 543K 23.68% | 611K 12.52% | |
average receivables | |||||||||||
book value per share | 12.28K - | 5.03K 59.04% | 12.00K 138.62% | 17.50K 45.88% | 5.75K 67.12% | 2.42K 57.92% | 416.21 82.81% | 69.49 83.30% | 13.69 80.31% | 10.25 25.12% | |
capex per share | -712.82 - | -39.93 94.40% | -3.54 91.13% | -64.69 1,725.60% | -36.99 42.81% | -9.77 73.59% | -0.89 90.84% | -0.15 83.40% | -0.06 60.83% | -0.10 79.01% | |
capex to depreciation | -1.01 - | -0.06 93.81% | -0.01 88.39% | -0.19 2,566.29% | -0.16 14.95% | -0.71 334.07% | -0.04 94.78% | -0.12 234.40% | -0.21 66.10% | -0.36 73.70% | |
capex to operating cash flow | 0.05 - | 0.00 93.88% | 0.00 90.04% | 0.01 1,987.46% | 0.00 48.34% | 0.01 59.87% | 0.00 77.96% | 0.00 269.62% | 0.01 102.23% | 0.02 75.52% | |
capex to revenue | |||||||||||
cash per share | 13.31K - | 11.44K 14.12% | 14.31K 25.16% | 19.98K 39.58% | 7.35K 63.22% | 2.50K 65.92% | 492.17 80.35% | 70.60 85.66% | 14.38 79.64% | 10.64 25.98% | |
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.12 - | 0.12 1.51% | 0.08 33.99% | 0.04 52.17% | 0.06 65.50% | 0.01 91.03% | 0.14 2,489.53% | 0.05 66.96% | 0.06 29.26% | 0.05 16.21% | |
debt to equity | 0.16 - | 0.33 109.45% | 0.10 69.88% | 0.04 55.35% | 0.08 91.34% | 0.01 92.63% | 0.24 3,691.84% | 0.05 77.41% | 0.07 36.02% | 0.06 16.66% | |
dividend yield | |||||||||||
earnings yield | -0.21 - | -0.16 26.42% | -0.17 11.08% | -0.18 2.89% | -1.05 485.93% | -6.14 482.13% | -5.53 9.88% | -1.62 70.72% | -0.65 59.87% | -2.82 333.81% | |
enterprise value | 169.16M - | 105.00M 37.93% | 171.96M 63.77% | 110.06M 36.00% | 13.31M 87.91% | -9.03M 167.82% | -3.07M 65.93% | -12.88M 318.96% | -2.50M 80.60% | -11.79M 371.86% | |
enterprise value over ebitda | -9.27 - | -6.15 33.69% | -7.94 29.22% | -4.72 40.59% | -0.55 88.25% | 17.66 3,286.31% | 0.29 98.34% | 1.47 402.15% | 0.26 82.15% | 1.16 340.55% | |
ev to operating cash flow | -11.35 - | -6.87 39.46% | -10.53 53.29% | -6.57 37.57% | -0.68 89.72% | 0.73 208.42% | 0.30 59.33% | 1.35 353.24% | 0.28 79.11% | 1.12 298.57% | |
ev to sales | |||||||||||
free cash flow per share | -14.91K - | -13.03K 12.63% | -11.58K 11.13% | -10.19K 12.01% | -11.24K 10.35% | -1.86K 83.45% | -769.79 58.62% | -34.68 95.50% | -6.75 80.54% | -6.93 2.65% | |
free cash flow yield | -0.09 - | -0.13 52.23% | -0.09 34.83% | -0.13 50.84% | -0.78 501.90% | -1.64 111.01% | -4.67 184.01% | -1.71 63.29% | -0.59 65.74% | -2.95 402.35% | |
graham net net | 9.31K - | 2.28K 75.50% | 10.87K 376.47% | 16.45K 51.39% | 5.11K 68.94% | 2.16K 57.65% | 213.21 90.15% | 60.73 71.51% | 11.62 80.87% | 8.64 25.62% | |
graham number | 100.97K - | 41.99K 58.41% | 79.83K 90.12% | 74.70K 6.43% | 44.39K 40.57% | 19.46K 56.16% | 2.92K 84.98% | 226.44 92.25% | 47.97 78.82% | 39.08 18.52% | |
income quality | 0.38 - | 0.83 116.61% | 0.49 41.16% | 0.71 45.71% | 0.74 3.04% | 0.53 28.58% | 0.87 65.87% | 1.05 20.51% | 0.89 14.84% | 1.00 11.67% | |
intangibles to total assets | 0.01 - | 0 100% | 0 | 0.00 Infinity% | 0 100% | 0 | 0.00 Infinity% | 0.00 85.27% | 0 100% | 0 | |
interest coverage | -146.30 - | -131.17 10.34% | -130.22 0.72% | -155.25 19.22% | -332.34 114.07% | -61.98 81.35% | -45.26 26.97% | -478.79 957.78% | -70.53 - | ||
interest debt per share | 2.04K - | 1.76K 13.75% | 1.31K 25.91% | 864.57 33.77% | 527.03 39.04% | 45.99 91.27% | 116.89 154.15% | 3.76 96.78% | 0.99 73.70% | 0.72 27.66% | |
inventory turnover | |||||||||||
invested capital | 0.16 - | 0.33 109.45% | 0.10 69.88% | 0.04 55.35% | 0.08 91.34% | 0.01 92.63% | 0.24 3,691.84% | 0.05 77.41% | 0.07 36.02% | 0.06 16.66% | |
market cap | 181.13M - | 116.52M 35.67% | 190.49M 63.47% | 130.25M 31.62% | 25.37M 80.52% | 7.53M 70.30% | 2.21M 70.62% | 5.59M 152.62% | 15.22M 172.25% | 3.61M 76.28% | |
net current asset value | 10.40M - | 4.18M 59.81% | 15.88M 279.99% | 28.02M 76.48% | 9.87M 64.77% | 14.86M 50.53% | 3.04M 79.53% | 16.93M 456.79% | 15.49M 8.53% | 14.53M 6.21% | |
net debt to ebitda | 0.66 - | 0.67 2.87% | 0.86 26.87% | 0.87 1.17% | 0.50 41.98% | 32.41 6,352.65% | 0.50 98.45% | 2.11 318.70% | 1.86 11.72% | 1.51 18.85% | |
net income per share | -36.91K - | -15.59K 57.77% | -23.61K 51.47% | -14.17K 39.98% | -15.22K 7.42% | -6.95K 54.34% | -912.63 86.87% | -32.80 96.41% | -7.47 77.21% | -6.62 11.35% | |
operating cash flow per share | -14.20K - | -12.99K 8.53% | -11.57K 10.88% | -10.12K 12.54% | -11.20K 10.69% | -1.85K 83.48% | -768.90 58.45% | -34.53 95.51% | -6.69 80.63% | -6.82 1.99% | |
payables turnover | |||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -2.28 - | -1.10 51.89% | -1.53 39.10% | -0.68 55.82% | -1.90 181.97% | -2.52 32.15% | -1.32 47.68% | -0.41 68.59% | -0.45 9.90% | -0.54 19.02% | |
revenue per share | |||||||||||
roe | -3.01 - | -3.10 3.10% | -1.97 36.52% | -0.81 58.86% | -2.65 226.74% | -2.87 8.50% | -2.19 23.61% | -0.47 78.48% | -0.55 15.70% | -0.65 18.38% | |
roic | -1.92 - | -2.32 20.64% | -1.59 31.18% | -0.78 51.34% | -2.43 213.61% | -1.55 36.11% | -1.45 6.81% | -0.43 70.48% | -0.48 11.60% | -0.59 22.71% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 12.28K - | 5.03K 59.04% | 12.00K 138.62% | 17.50K 45.88% | 5.75K 67.12% | 2.42K 57.92% | 416.21 82.81% | 69.49 83.30% | 13.69 80.31% | 10.25 25.12% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 12.76M - | 5.92M 53.62% | 16.93M 186.06% | 28.87M 70.54% | 10.11M 64.98% | 16.11M 59.36% | 5.56M 65.51% | 19.18M 245.10% | 18.11M 5.54% | 15.75M 13.08% | |
tangible book value per share | 12.15K - | 5.03K 58.62% | 12.00K 138.62% | 17.46K 45.49% | 5.75K 67.04% | 2.42K 57.92% | 414.27 82.89% | 69.45 83.23% | 13.69 80.30% | 10.25 25.12% | |
working capital | 12.33M - | 5.78M 53.15% | 17.43M 201.61% | 29.00M 66.44% | 10.69M 63.13% | 14.92M 39.52% | 4.12M 72.39% | 17.68M 329.22% | 16.53M 6.53% | 15.13M 8.45% |
All numbers in USD (except ratios and percentages)